Table 4.
Stratified analyses | No. of patients | No. of studies | Model | Pooled HR (95%CI) | P-value | PD-value | Heterogeneity | |
---|---|---|---|---|---|---|---|---|
I2 | PH-value | |||||||
Assessment time | 0.005 | |||||||
In-hospital mortality | 1,129 | 2 | Random | 1.002 (0.933–1.076) | 0.961 | 88.3% | 0.003 | |
30-day mortality | 613 | 3 | Random | 1.384 (0.985–1.945) | 0.061 | 85.4% | 0.001 | |
90-day mortality | 1,720 | 4 | Random | 1.489 (1.068–2.075) | 0.019 | 92.2% | <0.001 | |
One-year mortality | 593 | 2 | Random | 1.196 (0.817–1.750) | 0.358 | 73.9% | 0.050 | |
Clinical characteristic | ||||||||
Hemorrhagic stroke subtypes | 0.005 | |||||||
ICH | 1,997 | 6 | Random | 1.090 (1.004–1.182) | 0.039 | 85.7% | <0.001 | |
SAH | 929 | 3 | Random | 1.125 (1.002–1.263) | 0.046 | 90.4% | <0.001 | |
Hematoma size | 0.005 | |||||||
<14 ml | 737 | 3 | Random | 1.348 (1.067–1.702) | 0.012 | 66.3% | 0.052 | |
≥14 ml | 1,596 | 4 | Random | 1.061 (0.958–1.174) | 0.255 | 90.5% | <0.001 | |
Presence of IVH | 0.024 | |||||||
<25% | 389 | 2 | Random | 2.027 (0.857–4.798) | 0.108 | 63.8% | 0.096 | |
≥25% | 1,191 | 2 | Random | 1.025 (0.916–1.146) | 0.670 | 93.3% | <0.001 | |
Demographic factors | ||||||||
Age | 0.011 | |||||||
<65 | 962 | 3 | Random | 1.112 (0.989–1.250) | 0.076 | 90.1% | <0.001 | |
≥65 | 1,645 | 5 | Random | 1.080 (0.997–1.170) | 0.059 | 87.1% | <0.001 | |
Gender distribution | 0.005 | |||||||
Male dominant | 1,301 | 5 | Random | 1.944 (1.281–2.951) | 0.002 | 89.6% | <0.001 | |
Balanced | 855 | 1 | Random | 0.970 (0.950–0.991) | 0.006 | - | - | |
Female dominant | 770 | 3 | Random | 1.051 (1.005–1.100) | 0.030 | 55.8% | 0.079 | |
Country | 0.005 | |||||||
Eastern | 1,367 | 5 | Random | 1.115 (1.011–1.229) | 0.029 | 86.5% | <0.001 | |
Western | 1,559 | 4 | Random | 1.083 (0.993–1.181) | 0.072 | 87.5% | <0.001 | |
Vascular risk factors | ||||||||
Presence of hypertension | 0.005 | |||||||
<55% | 274 | 1 | Fixed | 1.033 (1.012–1.054) | 0.002 | 0.0% | 0.678 | |
≥55% and <65% | 655 | 2 | Random | 2.743 (0.849–8.863) | 0.092 | 90.6% | 0.001 | |
≥65% and <75% | 609 | 3 | Random | 1.214 (1.035–1.425) | 0.017 | 78.1% | 0.010 | |
≥75% | 1,388 | 3 | Random | 0.978 (0.923–1.037) | 0.458 | 68.3% | 0.024 | |
Presence of diabetes mellitus | 0.011 | |||||||
<25% | 1,752 | 7 | Random | 1.177 (1.072–1.291) | 0.001 | 87.1% | <0.001 | |
≥25% | 855 | 1 | Fixed | 0.970 (0.950–0.991) | 0.006 | 0.0% | 0.740 | |
Presence of hyperlipidemia | 0.161 | |||||||
<25% | 177 | 1 | Random | 1.160 (1.016–1.325) | 0.028 | |||
≥25% | 1,063 | 2 | Random | 1.034 (0.949–1.126) | 0.449 | 90.4% | <0.001 | |
Presence of current smoking | 0.011 | |||||||
<35% | 1,928 | 5 | Random | 1.158 (1.033–1.297) | 0.011 | 91.6% | <0.001 | |
Methodological factors | ||||||||
Sample time& | 0.002 | |||||||
On admission | 1,398 | 3 | Random | 1.003 (0.950–1.059) | 0.916 | 74.7% | 0.008 | |
Within 24 h | 1,254 | 5 | Random | 1.965 (1.313–2.941) | 0.001 | 86.4% | <0.001 | |
Cutoff value | 0.026 | |||||||
<4 | 855 | 1 | Fixed | 0.970 (0.950–0.991) | 0.006 | 0.0% | 0.740 | |
≥4 | 1,589 | 6 | Random | 1.626 (1.221–2.166) | 0.001 | 85.2% | <0.001 | |
Definition of cutoff value | 0.005 | |||||||
ROC curve analysis | 1,445 | 6 | Random | 1.547 (1.205–1.987) | 0.001 | 87.0% | <0.001 | |
4th quartile | 1,207 | 2 | Random | 0.972 (0.940–1.005) | 0.091 | 41.8% | 0.179 | |
Continuous variable | 274 | 1 | Fixed | 1.033 (1.012–1.054) | 0.002 | 0.0% | 0.678 | |
HR calculation | 0.011 | |||||||
Multivariate | 2,607 | 8 | Random | 1.080 (1.018–1.146) | 0.011 | 88.7% | <0.001 |
ICH, intracerebral hemorrhage; SAH, subarachnoid hemorrhage; IVH, intraventricular hemorrhage.
#Onset time was defined as time from stroke onset to recruitment/admission/diagnosis.
Sample time was defined as time from stroke onset to take blood sample.
‡HRs were extracted from multivariate Cox proportional hazards models, univariate Cox proportional hazards models, or survival curve analysis.